CCM · NYSE · ·
US$3.32-4.5%9月29日 收盘
取自公司自己的 6-K 文件。
Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China.
公司自己的描述,取自公告末尾。
引述和公司简介来自 Concord Medical Services Holdings Ltd 于 2025年9月26日 随业绩提交的 6-K 文件;表格根据其季度报告编制。 在 EDGAR 上阅读公告 股价已按拆股和分红复权。
暂无 Concord Medical Services Holdings Ltd 的业绩电话会文字记录。